Clinical Trial

Endoscopic Retrograde Cholangiopancreatography

Name: Endoscopic Retrograde Cholangiopancreatography — clinical trial record (NCT07490132)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Trial Details

NCT Number	NCT07490132
Lead Sponsor	Methodist Health System
Conditions	Gastro-Intestinal Disorder
Enrollment	100 participants
Start Date	2026-02
Primary Completion	2027-02 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-03-24